AC
Actuate Therapeutics Inc (ACTU)
NASDAQ·Healthcare·Biotechnology
$2.89
+1.40%
Mkt Cap $68.45M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$21.00
Range $21.00 – $21.00
Implied Upside
+626.6%
Consensus $21.00 vs current $2.89
NASDAQ·Healthcare·Biotechnology
$2.89
+1.40%
Mkt Cap $68.45M
No recent rating data.
Price Target (1 analysts)
$21.00
Range $21.00 – $21.00
+626.6%
Consensus $21.00 vs current $2.89